Providence Therapeutics: Advancing Lipid Nanoparticle Technology At Providence Therapeutics, we understand the critical role that lipid nanoparticles (LNPs) play in the development and delivery of mRNA-based therapeutics. With the global LNP demand expected to grow significantly in the future, our focus on this technology is strategically aligned with industry trends. Why Lipids Matter: - Extensive Library: We have developed a library of over 200 rationally designed ionizable lipids, intended for applications including cancer vaccines, infectious diseases, and gene delivery. - Manufacturability: Our ionizable lipids are first screened to ensure efficient manufacture into a stable lipid nanoparticle. - Proven Efficacy: Our lipid technology has been rigorously tested, demonstrating its effectiveness in enhancing the delivery of mRNA, both in vitro and in vivo, across multiple therapeutic areas. - Strategic Growth: As we continue to advance our mRNA platform, lipid technology remains central to our innovation strategy, opening new avenues for collaboration and enhancing the efficacy and safety of our therapeutic offerings. We believe our progress in lipid technology not only strengthens our current pipeline but also positions us as a leader in the rapidly growing field of mRNA therapeutics. If you would like to know more about our lipids or our programs in different therapeutic areas, send us a message at [email protected]
Providence Therapeutics
Biotechnology Research
Calgary, Alberta 5,056 followers
Where Hope and Science Intersect
About us
Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company focused on drug development and platform development. The Providence mRNA Medicines platform is comprised of four integrated platforms: 1) mRNA Medicines Platform, 2) NextGen lipid nanoparticles (LNP), 3) Manufacturing Platform and 4) Regulatory Platform. Providence’s mRNA and NextGen LNP platform offer an end-to-end solution for designing codon-optimized ultrapure mRNA that can be formulated in application optimized LNP. The Providence proprietary NextGen LNP, consists of rationally designed lipids that have been tested for suitability for programs in oncology, infectious diseases and gene delivery. Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. For more information, please visit providencetherapeutics.com
- Website
-
http://www.providencetherapeutics.com
External link for Providence Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Calgary, Alberta
- Type
- Privately Held
- Founded
- 2015
- Specialties
- mRNA therapeutics, personalized vaccines, cancer vaccines, lipid nanoparticles, COVID-19 Vaccine, and biotech
Locations
-
Primary
120, 8832 Blackfoot Trail
Calgary, Alberta T2J 3J1, CA
Employees at Providence Therapeutics
-
Honourable Ken Hughes, ECA
Chair of the Board, Providence Therapeutics, Entrepreneur and Community Leader
-
Aleksandra Pastrak MD, PhD
Chief Medical Officer at Providence Therapeutics
-
Jordan Schwartz, PhD
Leader and Innovator in mRNA Therapeutics
-
Rebecca Malott
Scientist | Vaccine Development | Analytical Assay Development
Updates
-
We had an amazing time at the University of Calgary Industry Career Fair yesterday! It was a pleasure meeting so many bright and talented students eager to make an impact! Thank you to everyone to stopped by to chat with Aarushi Jain and Amelia Shortt!
-
We are thrilled to share that our recent Greens & Giving Golf Tournament raised $16,810 for the University of Calgary Clark H. Smith Tumour and Related Tissue Bank! This brings our total amount over the last three years to over $41,000! This was a huge success and we couldn't be prouder of the impact this will make! It is moments like these that highlight our collective commitment to giving back and making a difference in our community! Take a look at some photos from the day here! https://lnkd.in/gaYyQcKC
-
We are proud to have had Rebecca Malott represent us as a guest panelist at University of Calgary's 2024 Postdoc Appreciation Week - Kick-Off Breakfast! Rebecca shared invaluable insights on transition from academia to industry, offering practical advice on leveraging research skills, building industry networks, and exploring career opportunities. A big thank you to UCalgary for inviting us to be part of such a meaningful event, and to all of the panelists and postdoc participants for their contributions! 🙌
-
Providence Therapeutics reposted this
We had a fantastic time at the Providence Therapeutics Greens and Giving tournament! Got to meet lots of awesome people and play some great golf on a beautiful day! All while supporting an amazing company, can’t wait to do it again next year. #greensandgiving #aboutstaffing
-
🌟 Exciting Investment Opportunity🌟 As we continue to make strides in our research, some of you have expressed interest in being a part of our journey. We're thrilled to announce that we are opening up investment opportunities to our dedicated followers. If you believe in groundbreaking biotechnology and want to contribute to our mission, we invite you to connect with us directly. For more details, please reach out to [email protected]. We're excited to explore this new chapter with you!
-
We are reaching out to our extended community with a personal and heartfelt request for support. One of our dedicated team members is currently facing a challenging situation as their young son has become dependent on a feeding tube. Despite their best efforts, he hasn't been able to be weaned off, leading to additional complications. After extensive research they've found hope in a specialized program in Austria with a 90% success rate, but they need our help to make it happen. We're rallying behind them to raise the necessary funds for this life-changing treatment. If you are able, please consider donating or sharing their story within your networks! 💙 https://gofund.me/72bfdeca
-
A heartfelt farewell to some of our amazing interns as they begin to wrap up their time with us! Your dedication, creativity and hard work have made a lasting impact. As Dr. Seuss said, "You're off to great places, today is your day!" We are excited to see where your journeys take you next. Thank you for being a part of our team! Jessica Mahfoud Quinn Kisilevich Karam Senjar Maria Albaba Vivian Phung
-
2
-
We are thrilled to have our friends from Ontario Institute for Cancer Research join us this week to celebrate our inspiring new partnership! This collaboration will open up new opportunities for OICR researchers to access mRNA technology to translate discoveries into treatments.
-
Join us for our 3rd Annual Greens & Giving Golf Tournament in support of the University of Calgary Clark H. Smith Tumour and Related Tissue Bank! What: 18 holes of golf in a shotgun start and best ball format along with a delicious lunch plus prizes! When: Friday, September 13th, 2024 Where: D'Arcy Ranch Golf Club How (much): $150 early-bird pricing per golfer with 100% of your registration fee going to the Tumour and Related Tissue Bank How (to register/sponsor): Check out https://lnkd.in/gKQtWCPK We hope to see you on the greens! ⛳
Event homepage of '3rd Annual Providence Therapeutics Greens & Giving'
app.eventcaddy.com